| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 3.35e-11 | 11 | 132 | 6 | GO:0098973 | |
| GeneOntologyMolecularFunction | kinase binding | FMR1 TTC28 PDGFRB PPM1D POTEF KIF1B ACTB ACTG1 PTPN23 POTEKP CBLB PTK2 STAT3 SLC12A5 POTEE WWC2 KIF14 PAX6 YWHAQ PLG POTEI FERMT2 NBR1 BANK1 PRLR WWC1 | 8.65e-10 | 969 | 132 | 26 | GO:0019900 |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 5.86e-08 | 32 | 132 | 6 | GO:0099186 | |
| GeneOntologyMolecularFunction | protein kinase binding | FMR1 PDGFRB PPM1D POTEF ACTB ACTG1 PTPN23 POTEKP CBLB PTK2 STAT3 SLC12A5 POTEE KIF14 PAX6 YWHAQ POTEI FERMT2 NBR1 BANK1 PRLR | 2.80e-07 | 873 | 132 | 21 | GO:0019901 |
| GeneOntologyMolecularFunction | structural constituent of synapse | 3.21e-07 | 42 | 132 | 6 | GO:0098918 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 2.53e-05 | 130 | 132 | 7 | GO:0005200 | |
| GeneOntologyMolecularFunction | insulin-like growth factor receptor activity | 1.30e-04 | 3 | 132 | 2 | GO:0005010 | |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 3.78e-08 | 31 | 131 | 6 | GO:0098974 | |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 8.16e-08 | 35 | 131 | 6 | GO:0099188 | |
| GeneOntologyBiologicalProcess | actin filament-based process | KRT8 KLHL1 PDGFRB POTEF ACTB ACTG1 ARHGEF18 POTEKP NEB POTEE MRTFB ATP2C1 PHPT1 AKAP9 NISCH SCN4A PCDH15 FGF7 CTNNA2 POTEI FERMT2 | 2.97e-07 | 912 | 131 | 21 | GO:0030029 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | KRT8 KLHL1 PDGFRB POTEF ACTB ACTG1 ARHGEF18 POTEKP NEB POTEE MRTFB ATP2C1 PHPT1 NISCH PCDH15 FGF7 CTNNA2 POTEI FERMT2 | 7.75e-07 | 803 | 131 | 19 | GO:0030036 |
| GeneOntologyBiologicalProcess | growth | PDGFRB ARMC12 KIF26B TTC3 PTK2 STAT3 SLC12A5 KMT2C WWC2 IGF1R WDR11 FGF20 PCDH15 KIF14 ING4 FGF7 ATM PLG FTO ENO1 CDH4 PRLR WWC1 | 2.99e-06 | 1235 | 131 | 23 | GO:0040007 |
| GeneOntologyBiologicalProcess | developmental growth | PDGFRB KIF26B TTC3 PTK2 STAT3 SLC12A5 KMT2C WWC2 IGF1R WDR11 FGF20 PCDH15 FGF7 ATM PLG FTO CDH4 PRLR WWC1 | 4.93e-06 | 911 | 131 | 19 | GO:0048589 |
| GeneOntologyBiologicalProcess | axonogenesis | POTEF ACTB ACTG1 POTEKP TTC3 PTK2 POTEE IGF1R NRXN3 CTNNA2 PAX6 POTEI CDH4 EPHA10 | 1.51e-05 | 566 | 131 | 14 | GO:0007409 |
| GeneOntologyBiologicalProcess | establishment of cell polarity | 1.77e-05 | 177 | 131 | 8 | GO:0030010 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of cell polarity | 3.97e-05 | 257 | 131 | 9 | GO:0007163 | |
| GeneOntologyBiologicalProcess | neuron projection development | SETX KLHL1 FMR1 POTEF ACTB ACTG1 POTEKP TTC3 PTK2 SLC12A5 POTEE IGF1R MRTFB NRXN3 PCDH15 CTNNA2 PAX6 POTEI CDH4 SF3A2 EPHA10 | 5.91e-05 | 1285 | 131 | 21 | GO:0031175 |
| GeneOntologyBiologicalProcess | axon development | POTEF ACTB ACTG1 POTEKP TTC3 PTK2 POTEE IGF1R NRXN3 CTNNA2 PAX6 POTEI CDH4 EPHA10 | 5.96e-05 | 642 | 131 | 14 | GO:0061564 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | POTEF ACTB ACTG1 POTEKP TTC3 PTK2 POTEE IGF1R NRXN3 PCDH15 CTNNA2 PAX6 POTEI CDH4 EPHA10 | 8.26e-05 | 748 | 131 | 15 | GO:0048667 |
| GeneOntologyBiologicalProcess | neuron development | SETX KLHL1 FMR1 POTEF ACTB ACTG1 PBX4 POTEKP TTC3 PTK2 SLC12A5 POTEE IGF1R MRTFB NRXN3 PCDH15 CTNNA2 PAX6 POTEI CDH4 SF3A2 EPHA10 | 1.31e-04 | 1463 | 131 | 22 | GO:0048666 |
| GeneOntologyBiologicalProcess | cell junction organization | FMR1 POTEF ACTB ACTG1 PTPN23 POTEKP PTK2 NEDD8 POTEE IGF1R NRXN3 FGF7 CTNNA2 POTEI PATJ FERMT2 CDH4 | 1.48e-04 | 974 | 131 | 17 | GO:0034330 |
| GeneOntologyBiologicalProcess | postsynapse organization | 1.78e-04 | 313 | 131 | 9 | GO:0099173 | |
| GeneOntologyBiologicalProcess | positive regulation of cell motility | MIA3 PDGFRB ACTG1 CASP8 PTK2 STAT3 IGF1R PHPT1 BSG FGF7 ATM PAX6 PLG FERMT2 | 2.13e-04 | 725 | 131 | 14 | GO:2000147 |
| GeneOntologyBiologicalProcess | regulation of transepithelial transport | 2.38e-04 | 4 | 131 | 2 | GO:0150111 | |
| GeneOntologyBiologicalProcess | positive regulation of locomotion | MIA3 PDGFRB ACTG1 CASP8 PTK2 STAT3 IGF1R PHPT1 BSG FGF7 ATM PAX6 PLG FERMT2 | 2.70e-04 | 742 | 131 | 14 | GO:0040017 |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 4.28e-08 | 32 | 131 | 6 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 4.28e-08 | 32 | 131 | 6 | GO:0043189 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 3.60e-07 | 45 | 131 | 6 | GO:1902562 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 2.10e-06 | 94 | 131 | 7 | GO:0000123 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 4.14e-06 | 104 | 131 | 7 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 5.66e-06 | 109 | 131 | 7 | GO:1902493 | |
| GeneOntologyCellularComponent | sarcolemma | 1.98e-04 | 190 | 131 | 7 | GO:0042383 | |
| GeneOntologyCellularComponent | cell leading edge | PDGFRB ANXA2P2 ACTB CASP8 HCN2 PTK2 SLC12A5 PHPT1 CTNNA2 FERMT2 WWC1 | 3.16e-04 | 500 | 131 | 11 | GO:0031252 |
| GeneOntologyCellularComponent | actin filament | 3.20e-04 | 146 | 131 | 6 | GO:0005884 | |
| GeneOntologyCellularComponent | myofibril | 3.31e-04 | 273 | 131 | 8 | GO:0030016 | |
| GeneOntologyCellularComponent | supramolecular fiber | KRT8 KIF26B POTEF KIF1B ACTB ACTG1 POTEKP NEB EML3 RYR1 POTEE SPHKAP KIF14 YWHAQ POTEI FERMT2 ENO1 NBR1 | 4.07e-04 | 1179 | 131 | 18 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KRT8 KIF26B POTEF KIF1B ACTB ACTG1 POTEKP NEB EML3 RYR1 POTEE SPHKAP KIF14 YWHAQ POTEI FERMT2 ENO1 NBR1 | 4.41e-04 | 1187 | 131 | 18 | GO:0099081 |
| GeneOntologyCellularComponent | axon | SETX FMR1 POTEF KIF1B ACTB ACTG1 POTEKP HCN2 POTEE IGF1R SCN4A CTNNA2 POTEI ENO1 UNC80 | 4.71e-04 | 891 | 131 | 15 | GO:0030424 |
| GeneOntologyCellularComponent | contractile muscle fiber | 4.94e-04 | 290 | 131 | 8 | GO:0043292 | |
| GeneOntologyCellularComponent | cation channel complex | 7.11e-04 | 235 | 131 | 7 | GO:0034703 | |
| GeneOntologyCellularComponent | dense body | 8.02e-04 | 7 | 131 | 2 | GO:0097433 | |
| GeneOntologyCellularComponent | sarcomere | 9.98e-04 | 249 | 131 | 7 | GO:0030017 | |
| GeneOntologyCellularComponent | actin cytoskeleton | ANXA2P2 POTEF ACTB ACTG1 POTEKP NEB PTK2 POTEE CTNNA2 POTEI FERMT2 | 1.02e-03 | 576 | 131 | 11 | GO:0015629 |
| GeneOntologyCellularComponent | plasma membrane protein complex | KRT8 ANXA2P2 CASP8 HCN2 RYR1 SLC5A3 IGF1R AKAP9 SCN4A CTNNA2 PATJ EFCAB7 CDH4 | 1.32e-03 | 785 | 131 | 13 | GO:0098797 |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 1.73e-03 | 137 | 131 | 5 | GO:0019897 | |
| GeneOntologyCellularComponent | blood microparticle | 2.15e-03 | 144 | 131 | 5 | GO:0072562 | |
| GeneOntologyCellularComponent | cell cortex | 2.38e-03 | 371 | 131 | 8 | GO:0005938 | |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | TRPM6 FRAS1 MCPH1 PDGFRB PHF6 ACTG1 NEB HCN2 PTK2 STAT3 SLC5A3 MRTFB NRXN3 IGF2R WDR11 BSG NISCH SCN4A CTNNA2 PAX6 FTO MOCOS | 3.45e-05 | 1124 | 107 | 22 | MP:0011112 |
| MousePheno | perinatal lethality | MIA3 MCPH1 PDGFRB KIF26B KIF1B PHF6 ACTG1 RYR1 STAT3 SLC12A5 SLC5A3 KMT2C IGF1R MRTFB IGF2R WDR11 KCNJ13 SCN4A CTNNA2 PAX6 UNC80 MOCOS | 3.74e-05 | 1130 | 107 | 22 | MP:0002081 |
| MousePheno | respiratory failure | 3.85e-05 | 165 | 107 | 8 | MP:0001953 | |
| MousePheno | ectopic Purkinje cell | 4.26e-05 | 26 | 107 | 4 | MP:0000885 | |
| MousePheno | decreased cochlear hair cell stereocilia number | 4.26e-05 | 26 | 107 | 4 | MP:0004523 | |
| MousePheno | decreased respiration | 4.76e-05 | 170 | 107 | 8 | MP:0014274 | |
| MousePheno | eye opacity | 5.03e-05 | 10 | 107 | 3 | MP:0009859 | |
| MousePheno | abnormal neuron physiology | SETX FMR1 MCPH1 KIF1B PHF6 HCN2 PEX5L WDR11 PCDH15 KIF14 FGF7 PAX6 YWHAQ PLG PRLR | 5.43e-05 | 604 | 107 | 15 | MP:0004811 |
| MousePheno | abnormal glucose tolerance | NR2C2 KRT8 SETX PPM1D VPS13C ACTB SLC12A5 PHPT1 WDR11 NISCH SCN4A ATM PAX6 FTO NBR1 PRLR KNL1 | 9.44e-05 | 787 | 107 | 17 | MP:0005291 |
| MousePheno | postnatal growth retardation | FRAS1 PBX4 NEB RYR1 STAT3 SLC12A5 KMT2C IGF1R WDR11 NISCH SCN4A PCDH15 KIF14 ATM PLG FTO PRLR MOCOS | 1.17e-04 | 881 | 107 | 18 | MP:0001732 |
| MousePheno | abnormal postnatal growth | FRAS1 PBX4 NEB RYR1 STAT3 SLC12A5 KMT2C IGF1R WDR11 NISCH SCN4A PCDH15 KIF14 ATM PLG FTO PRLR MOCOS | 1.68e-04 | 907 | 107 | 18 | MP:0001731 |
| MousePheno | abnormal summary potential | 1.73e-04 | 3 | 107 | 2 | MP:0003470 | |
| MousePheno | decreased circulating enzyme level | 1.85e-04 | 263 | 107 | 9 | MP:0014451 | |
| MousePheno | abnormal respiratory system development | 2.26e-04 | 160 | 107 | 7 | MP:0003115 | |
| MousePheno | impaired branching involved in ureteric bud morphogenesis | 2.64e-04 | 41 | 107 | 4 | MP:0004936 | |
| MousePheno | abnormal head morphology | TRPM6 LIAS FRAS1 MIA3 MCPH1 PDGFRB KIF1B PTK2 RYR1 ATP2C1 AKAP9 WDR11 ADAMTS6 FGF20 NISCH KCNJ13 KIF14 PAX6 YWHAQ GOLGB1 | 2.88e-04 | 1120 | 107 | 20 | MP:0000432 |
| MousePheno | decreased circulating hormone level | NR2C2 VPS13C ACTB PHF6 PBX4 PHPT1 SPHKAP SCN4A ATM PAX6 FTO GRAMD1C PRLR | 2.92e-04 | 551 | 107 | 13 | MP:0014457 |
| MousePheno | abnormal prenatal growth/weight/body size | TRPM6 LIAS KRT8 MIA3 KIF1B ACTB ACTG1 CASP8 PTPN23 PTK2 RYR1 STAT3 SLC12A5 BPTF LIG3 IGF1R ATP2C1 IGF2R WDR11 KCNJ13 PAX6 YWHAQ ENO1 GOT2 | 3.17e-04 | 1493 | 107 | 24 | MP:0004196 |
| MousePheno | decreased outer hair cell stereocilia number | 3.27e-04 | 18 | 107 | 3 | MP:0004529 | |
| MousePheno | decreased enzyme/conezyme level | 3.27e-04 | 284 | 107 | 9 | MP:0014449 | |
| MousePheno | decreased hormone level | NR2C2 VPS13C ACTB PHF6 PBX4 STAT3 PHPT1 SPHKAP SCN4A ATM PAX6 FTO GRAMD1C PRLR | 3.37e-04 | 635 | 107 | 14 | MP:0014455 |
| MousePheno | abnormal kidney size | FRAS1 KIF26B CASP8 SLC12A5 IGF2R WDR11 ADAMTS6 FGF20 BSG ING4 FGF7 PLG CNR2 GOT2 MOCOS | 3.42e-04 | 714 | 107 | 15 | MP:0002706 |
| MousePheno | abnormal branching involved in ureteric bud morphogenesis | 3.80e-04 | 45 | 107 | 4 | MP:0010981 | |
| MousePheno | small kidney | FRAS1 KIF26B CASP8 SLC12A5 ADAMTS6 FGF20 ING4 FGF7 CNR2 GOT2 MOCOS | 4.06e-04 | 425 | 107 | 11 | MP:0002989 |
| MousePheno | decreased circulating alanine transaminase level | 4.57e-04 | 84 | 107 | 5 | MP:0002942 | |
| MousePheno | ectopic neuron | 4.87e-04 | 48 | 107 | 4 | MP:0011723 | |
| MousePheno | abnormal meiosis | 5.22e-04 | 241 | 107 | 8 | MP:0001930 | |
| MousePheno | hemorrhage | KRT8 FRAS1 MIA3 PDGFRB KIF1B ACTG1 CASP8 PTK2 SLC12A5 MRTFB IGF2R KCNJ13 PLG GOT2 | 5.28e-04 | 664 | 107 | 14 | MP:0001914 |
| Domain | Actin_CS | 5.52e-08 | 16 | 127 | 5 | IPR004001 | |
| Domain | ACTINS_2 | 7.78e-08 | 17 | 127 | 5 | PS00432 | |
| Domain | Actin/actin-like_CS | 1.07e-07 | 18 | 127 | 5 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 1.45e-07 | 19 | 127 | 5 | PS01132 | |
| Domain | Actin | 1.98e-06 | 31 | 127 | 5 | IPR004000 | |
| Domain | Actin | 1.98e-06 | 31 | 127 | 5 | PF00022 | |
| Domain | ACTIN | 1.98e-06 | 31 | 127 | 5 | SM00268 | |
| Domain | Secretoglobin_1C1/2 | 4.59e-05 | 2 | 127 | 2 | IPR028659 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | PDGFRB ACTB ACTG1 PTK2 KMT2C IGF1R FGF20 FGF7 ATM CTNNA2 CDH4 WWC1 CDK2 | 1.31e-05 | 439 | 100 | 13 | M42563 |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAB_C_D_TO_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 2.82e-05 | 9 | 100 | 3 | M47725 | |
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 1.36e-11 | 15 | 133 | 6 | 16824795 | |
| Pubmed | KRT8 DNAJC13 MIA3 PPM1D ACTB BMS1 ACTG1 PTPN23 UBLCP1 WWC2 IGF2R AKAP9 WDR11 BSG NUP210 MIOS KIF14 YWHAQ FTO NBR1 KNL1 | 5.79e-10 | 1049 | 133 | 21 | 27880917 | |
| Pubmed | DNAJC13 MIA3 FMR1 ACTB ARHGEF18 HCN2 PEX5L TTC3 DDB1 PTK2 SLC12A5 IGF2R AKAP9 NISCH SPHKAP MIOS CTNNA2 YWHAQ ENO1 GOLGB1 | 8.28e-10 | 963 | 133 | 20 | 28671696 | |
| Pubmed | FRAS1 KLHL1 TENT4B IQCH TTC28 POTEF ACTB ACTG1 ZFP14 POTEKP NEB POTEE ADAMTS6 ENO1 SF3A2 | 1.37e-09 | 513 | 133 | 15 | 25798074 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | KRT8 ANXA2P2 VPS13C ACTB ACTG1 DDB1 EML3 SLC5A3 MRTFB IGF2R NISCH PAX6 YWHAQ ENO1 GOLGB1 | 4.92e-09 | 564 | 133 | 15 | 21565611 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TRPM6 TENT4B FMR1 PDGFRB VPS13C BMS1 PHF6 ACTG1 TTC3 DDB1 DNTTIP2 LIG3 IGF2R GGCT BSG NUP210 MRPS9 KIF14 ATM ENO1 NBR1 GOT2 CDK2 | 4.94e-09 | 1425 | 133 | 23 | 30948266 |
| Pubmed | KRT8 POTEF ACTB ACTG1 NEB TTC3 UBLCP1 DNTTIP2 NEDD8 POTEE BPTF NRXN3 BSG SCN4A MRPS9 ATM YWHAQ POTEI ENO1 SF3A2 MED13 GOLGB1 | 3.03e-08 | 1442 | 133 | 22 | 35575683 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | KRT8 MIA3 TTC28 VPS13C KIF1B ACTG1 CASP8 PTPN23 DDB1 STAT3 MRTFB IGF2R WDR11 KIF14 YWHAQ FERMT2 CFAP97 | 3.11e-08 | 853 | 133 | 17 | 28718761 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DNAJC13 MIA3 MCPH1 VPS13C KIF1B PHF6 ARHGEF18 ZHX2 TTC3 UBLCP1 PTK2 BPTF KMT2C IGF1R MRTFB ATP2C1 WDR11 NUP210 PATJ NBR1 GOLGB1 MOCOS | 5.32e-08 | 1489 | 133 | 22 | 28611215 |
| Pubmed | Angiostatin and plasminogen share binding to endothelial cell surface actin. | 5.47e-08 | 3 | 133 | 3 | 15746964 | |
| Pubmed | 9.20e-08 | 202 | 133 | 9 | 24639526 | ||
| Pubmed | DNAJC13 MIA3 FMR1 PDGFRB DOCK9 ACTB ACTG1 ATP2C1 IGF2R WDR11 BSG NISCH NUP210 KIF14 YWHAQ ENO1 NBR1 MED13 GOLGB1 | 1.10e-07 | 1168 | 133 | 19 | 19946888 | |
| Pubmed | DNAJC13 MIA3 SETX ACTB BMS1 PHF6 ACTG1 PTPN23 UBLCP1 STAT3 NEDD8 BPTF IGF2R GGCT NUP210 CTNNA2 NBR1 SF3A2 GOT2 CDK2 | 1.17e-07 | 1297 | 133 | 20 | 33545068 | |
| Pubmed | FRAS1 TTC28 DOCK9 KIF1B PHF6 ZHX2 SLC12A5 AKAP9 NISCH SPHKAP PACS2 | 5.19e-07 | 407 | 133 | 11 | 12693553 | |
| Pubmed | 5.44e-07 | 5 | 133 | 3 | 22915798 | ||
| Pubmed | 6.56e-07 | 128 | 133 | 7 | 30995482 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | DNAJC13 MIA3 TENT4B PDGFRB ACTB PHF6 DNTTIP2 STAT3 NEDD8 IGF1R ATP2C1 IGF2R BSG NUP210 ZNF160 ENO1 SF3A2 GOLGB1 | 8.23e-07 | 1203 | 133 | 18 | 29180619 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | GALNTL6 LIAS SETX MCPH1 KIF26B VPS13C BMS1 PBX4 RYR1 POTEE KMT2C LIG3 ATM BANK1 | 9.62e-07 | 736 | 133 | 14 | 29676528 |
| Pubmed | NR2C2 FRAS1 DNAJC13 MIA3 BMS1 TTC3 DDB1 DNTTIP2 SLC5A3 IGF2R AKAP9 WDR11 BSG NISCH NUP210 MRPS9 ATM FERMT2 NBR1 GOLGB1 | 1.00e-06 | 1487 | 133 | 20 | 33957083 | |
| Pubmed | 1.08e-06 | 6 | 133 | 3 | 12679033 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | KRT8 SETX TTC28 KIF26B POTEF KIF1B STAT3 WWC2 IGF1R AKAP9 KIF14 YWHAQ PATJ CFAP97 GOLGB1 | 1.15e-06 | 861 | 133 | 15 | 36931259 |
| Pubmed | Proteomic and biochemical analysis of 14-3-3-binding proteins during C2-ceramide-induced apoptosis. | 1.17e-06 | 88 | 133 | 6 | 20618440 | |
| Pubmed | 1.71e-06 | 23 | 133 | 4 | 16637659 | ||
| Pubmed | 1.95e-06 | 96 | 133 | 6 | 23580065 | ||
| Pubmed | KRT8 POTEF DOCK9 ACTB PHF6 ACTG1 POTEKP DDB1 POTEE IGF2R NUP210 MRPS9 YWHAQ POTEI ENO1 GOT2 CDK2 | 2.08e-06 | 1153 | 133 | 17 | 29845934 | |
| Pubmed | 3.02e-06 | 8 | 133 | 3 | 9438420 | ||
| Pubmed | Four enzymes cooperate to displace histone H1 during the first minute of hormonal gene activation. | 3.02e-06 | 8 | 133 | 3 | 21447625 | |
| Pubmed | FMR1 DOCK9 KIF1B NEB TTC3 DNTTIP2 RYR1 AKAP9 ZNF160 ENO1 MED13 | 3.58e-06 | 497 | 133 | 11 | 23414517 | |
| Pubmed | TRPM6 MIA3 SETX DOCK9 ARHGEF18 PTPN23 TTC3 DNTTIP2 KMT2C AREL1 WWC2 IGF2R YWHAQ PATJ FERMT2 GOLGB1 | 4.19e-06 | 1084 | 133 | 16 | 11544199 | |
| Pubmed | 4.32e-06 | 110 | 133 | 6 | 27889896 | ||
| Pubmed | 4.52e-06 | 9 | 133 | 3 | 16364570 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | KRT8 TENT4B FMR1 ACTB BMS1 PHF6 DDB1 DNTTIP2 WDR11 BSG NUP210 MRPS9 KIF14 YWHAQ PATJ ENO1 SF3A2 | 6.53e-06 | 1257 | 133 | 17 | 36526897 |
| Pubmed | Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. | 6.85e-06 | 256 | 133 | 8 | 24189400 | |
| Pubmed | FMR1 VPS13C PTPN23 COL22A1 DNTTIP2 LIG3 ATP2C1 BSG NUP210 KIF14 TMCO3 GOLGB1 WWC1 | 6.93e-06 | 754 | 133 | 13 | 35906200 | |
| Pubmed | TTC28 ACTG1 PTPN23 STAT3 BPTF KMT2C MRTFB KIF14 YWHAQ PATJ ENO1 | 9.15e-06 | 549 | 133 | 11 | 38280479 | |
| Pubmed | 9.37e-06 | 191 | 133 | 7 | 33762435 | ||
| Pubmed | TTC28 ANXA2P2 PTPN23 MRTFB IGF2R BSG NISCH YWHAQ FERMT2 GOLGB1 | 9.56e-06 | 449 | 133 | 10 | 31732153 | |
| Pubmed | 1.06e-05 | 75 | 133 | 5 | 20644561 | ||
| Pubmed | 1.39e-05 | 469 | 133 | 10 | 27634302 | ||
| Pubmed | Beta- and gamma-cytoplasmic actins are required for meiosis in mouse oocytes. | 1.45e-05 | 2 | 133 | 2 | 21778137 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 29116649 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 20837466 | ||
| Pubmed | De novo mutations in the actin genes ACTB and ACTG1 cause Baraitser-Winter syndrome. | 1.45e-05 | 2 | 133 | 2 | 22366783 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 7681397 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 34076564 | ||
| Pubmed | A primate-specific POTE-actin fusion protein plays a role in apoptosis. | 1.45e-05 | 2 | 133 | 2 | 19669888 | |
| Pubmed | Genetic mutations in Ca2+ signaling alter dendrite morphology and social approach in juvenile mice. | 1.45e-05 | 2 | 133 | 2 | 30311737 | |
| Pubmed | Serum starvation and growth factor receptor expression in vascular smooth muscle cells. | 1.45e-05 | 2 | 133 | 2 | 16407661 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 26626498 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 3221869 | ||
| Pubmed | KIBRA promotes prostate cancer cell proliferation and motility. | 1.45e-05 | 2 | 133 | 2 | 27220053 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 24266654 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 28498494 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 37538000 | ||
| Pubmed | FAK and IGF-IR interact to provide survival signals in human pancreatic adenocarcinoma cells. | 1.45e-05 | 2 | 133 | 2 | 18263593 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 34695768 | ||
| Pubmed | R-cadherin is a Pax6-regulated, growth-promoting cue for pioneer axons. | 1.45e-05 | 2 | 133 | 2 | 14586016 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 21502360 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 6686106 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 20347606 | ||
| Pubmed | Beta and gamma-cytoplasmic actins display distinct distribution and functional diversity. | 1.45e-05 | 2 | 133 | 2 | 19638415 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 29953970 | ||
| Pubmed | STAT3 couples with 14-3-3σ to regulate BCR signaling, B-cell differentiation, and IgE production. | 1.45e-05 | 2 | 133 | 2 | 33045280 | |
| Pubmed | The role of insulin-like growth factor in Acrochordon Etiopathology. | 1.45e-05 | 2 | 133 | 2 | 33143702 | |
| Pubmed | Botulinum C2 toxin ADP-ribosylates cytoplasmic beta/gamma-actin in arginine 177. | 1.45e-05 | 2 | 133 | 2 | 3335520 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 1577857 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 26929199 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 3107886 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 22550182 | ||
| Pubmed | Multiple routes of endocytic internalization of PDGFRβ contribute to PDGF-induced STAT3 signaling. | 1.45e-05 | 2 | 133 | 2 | 27980069 | |
| Pubmed | Severe forms of Baraitser-Winter syndrome are caused by ACTB mutations rather than ACTG1 mutations. | 1.45e-05 | 2 | 133 | 2 | 23756437 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 23117476 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 34830460 | ||
| Pubmed | Cytochalasin D-induced actin gene expression in murine erythroleukemia cells. | 1.45e-05 | 2 | 133 | 2 | 8482333 | |
| Pubmed | Disruption of the protein interaction between FAK and IGF-1R inhibits melanoma tumor growth. | 1.45e-05 | 2 | 133 | 2 | 22894899 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 38678786 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 29265728 | ||
| Pubmed | Focal adhesion kinase (FAK) activates and stabilizes IGF-1 receptor. | 1.45e-05 | 2 | 133 | 2 | 19545541 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 26861122 | ||
| Pubmed | Multi-isotope imaging mass spectrometry reveals slow protein turnover in hair-cell stereocilia. | 1.45e-05 | 2 | 133 | 2 | 22246323 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 32349449 | ||
| Pubmed | Baraitser-Winter cerebrofrontofacial syndrome: Report of two adult siblings. | 1.45e-05 | 2 | 133 | 2 | 32506774 | |
| Pubmed | Differential arginylation of actin isoforms is regulated by coding sequence-dependent degradation. | 1.45e-05 | 2 | 133 | 2 | 20847274 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 38520674 | ||
| Pubmed | Intrinsic mitochondrial DNA repair defects in Ataxia Telangiectasia. | 1.45e-05 | 2 | 133 | 2 | 24342190 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 12061821 | ||
| Pubmed | PHF6 recruits BPTF to promote HIF-dependent pathway and progression in YAP-high breast cancer. | 1.45e-05 | 2 | 133 | 2 | 36967443 | |
| Pubmed | Ablation of Cbl-b provides protection against transplanted and spontaneous tumors. | 1.45e-05 | 2 | 133 | 2 | 17364027 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 11169399 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 38892470 | ||
| Pubmed | Wip1 phosphatase modulates ATM-dependent signaling pathways. | 1.45e-05 | 2 | 133 | 2 | 16949371 | |
| Pubmed | Prenatal presentation and diagnosis of Baraitser-Winter syndrome using exome sequencing. | 1.45e-05 | 2 | 133 | 2 | 32588558 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 28752190 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 18835089 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 27625340 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 15998644 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 11463827 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 28864772 | ||
| Pubmed | Lactylation-driven FTO targets CDK2 to aggravate microvascular anomalies in diabetic retinopathy. | 1.45e-05 | 2 | 133 | 2 | 38297099 | |
| Pubmed | Absence of Wip1 partially rescues Atm deficiency phenotypes in mice. | 1.45e-05 | 2 | 133 | 2 | 21765465 | |
| Interaction | ERRFI1 interactions | 1.96e-09 | 107 | 131 | 10 | int:ERRFI1 | |
| Interaction | YWHAZ interactions | NR2C2 KRT8 TTC28 COL6A6 KIF26B POTEF DOCK9 KIF1B ACTG1 ARHGEF18 POTEKP NEB ZHX2 EML3 NEDD8 WWC2 IGF1R AKAP9 NISCH KIF14 PACS2 ATM YWHAQ FERMT2 ENO1 PRLR CDK2 | 8.33e-08 | 1319 | 131 | 27 | int:YWHAZ |
| Interaction | ACTG2 interactions | 7.48e-07 | 49 | 131 | 6 | int:ACTG2 | |
| Interaction | ARF3 interactions | 1.21e-06 | 163 | 131 | 9 | int:ARF3 | |
| Interaction | YWHAG interactions | KRT8 TTC28 KIF26B POTEF DOCK9 KIF1B EML3 PTK2 DNTTIP2 STAT3 WWC2 IGF1R AKAP9 KIF14 PACS2 ING4 YWHAQ PATJ EFCAB7 NBR1 PRLR CFAP97 WWC1 CDK2 | 1.50e-06 | 1248 | 131 | 24 | int:YWHAG |
| Interaction | YWHAQ interactions | KRT8 TTC28 KIF26B POTEF KIF1B ACTB ACTG1 NEB ZHX2 EML3 NEDD8 WWC2 IGF1R KIF14 PACS2 YWHAQ PLG ENO1 BANK1 GOLGB1 WWC1 CDK2 | 3.03e-06 | 1118 | 131 | 22 | int:YWHAQ |
| Interaction | HNRNPC interactions | NR2C2 APOBEC3D ANXA2P2 ACTB PHF6 PABPC4L ZNF57 DNTTIP2 NEDD8 AKAP9 MRPS9 KIF14 PAX6 YWHAQ SF3A2 CDK2 | 3.69e-06 | 634 | 131 | 16 | int:HNRNPC |
| Interaction | NEK4 interactions | FRAS1 KLHL1 TENT4B IQCH TTC28 POTEF ACTB ACTG1 ZFP14 POTEKP NEB POTEE ADAMTS6 ENO1 SF3A2 | 5.90e-06 | 582 | 131 | 15 | int:NEK4 |
| Interaction | YARS1 interactions | 5.94e-06 | 149 | 131 | 8 | int:YARS1 | |
| Interaction | DYNLL1 interactions | NR2C2 FMR1 ACTB ACTG1 DDB1 EML3 KMT2C WWC2 AKAP9 KIF14 ATM PAX6 GOLGB1 WWC1 | 6.04e-06 | 510 | 131 | 14 | int:DYNLL1 |
| Interaction | DNMT1 interactions | 6.43e-06 | 254 | 131 | 10 | int:DNMT1 | |
| Interaction | DYNLL2 interactions | 8.72e-06 | 263 | 131 | 10 | int:DYNLL2 | |
| Interaction | SMARCA4 interactions | NR2C2 TENT4B FMR1 MCPH1 ACTB ACTG1 TTC3 DDB1 STAT3 BPTF KIF14 ATM PAX6 | 1.02e-05 | 462 | 131 | 13 | int:SMARCA4 |
| Interaction | TRAF6 interactions | NR2C2 KRT8 ACTB CASP8 TTC3 CBLB DDB1 STAT3 BSG ATM YWHAQ ENO1 BANK1 | 1.09e-05 | 465 | 131 | 13 | int:TRAF6 |
| Interaction | ZNF2 interactions | 1.36e-05 | 80 | 131 | 6 | int:ZNF2 | |
| Interaction | WDR1 interactions | 1.40e-05 | 220 | 131 | 9 | int:WDR1 | |
| Interaction | CLTA interactions | MIA3 FMR1 PTPN23 DNTTIP2 MRTFB IGF2R KIF14 ENO1 NBR1 CFAP97 CDK2 | 1.89e-05 | 351 | 131 | 11 | int:CLTA |
| Interaction | YWHAE interactions | KRT8 TTC28 KIF26B POTEF DOCK9 KIF1B ACTB TTC3 DDB1 NEDD8 WWC2 IGF1R AKAP9 NISCH KIF14 PACS2 YWHAQ FERMT2 EFCAB7 NBR1 WWC1 CDK2 | 1.90e-05 | 1256 | 131 | 22 | int:YWHAE |
| Interaction | POTEJ interactions | 2.19e-05 | 52 | 131 | 5 | int:POTEJ | |
| Interaction | KIF26B interactions | 2.19e-05 | 52 | 131 | 5 | int:KIF26B | |
| Interaction | ACTB interactions | NR2C2 FMR1 KIF26B POTEF KIF1B ACTB ACTG1 POTEKP NEB DDB1 FBXL4 NEDD8 POTEE MRTFB KIF14 YWHAQ PLG POTEI PATJ CDK2 | 2.27e-05 | 1083 | 131 | 20 | int:ACTB |
| Interaction | AASDHPPT interactions | 2.36e-05 | 88 | 131 | 6 | int:AASDHPPT | |
| Interaction | PEX5L interactions | 2.63e-05 | 54 | 131 | 5 | int:PEX5L | |
| Interaction | POTEE interactions | 2.76e-05 | 134 | 131 | 7 | int:POTEE | |
| Interaction | YWHAB interactions | KRT8 TTC28 KIF26B PPM1D POTEF DOCK9 KIF1B ACTB ACTG1 NEB EML3 WWC2 IGF1R AKAP9 KIF14 PACS2 YWHAQ ENO1 WWC1 | 3.05e-05 | 1014 | 131 | 19 | int:YWHAB |
| Interaction | H2AX interactions | NR2C2 MCPH1 PPM1D ANXA2P2 ACTB PABPC4L NEB DDB1 BPTF LIG3 KIF14 ATM YWHAQ ENO1 | 3.24e-05 | 593 | 131 | 14 | int:H2AX |
| Interaction | RHOF interactions | PDGFRB KIF26B DOCK9 ACTB NEDD8 POTEE LIG3 IGF2R WDR11 BSG NISCH KIF14 FERMT2 ENO1 GOLGB1 | 3.25e-05 | 673 | 131 | 15 | int:RHOF |
| Interaction | PHACTR2 interactions | 3.57e-05 | 29 | 131 | 4 | int:PHACTR2 | |
| Interaction | CFL1 interactions | NR2C2 ACTB ACTG1 ARHGEF18 STAT3 KIF14 YWHAQ ENO1 NBR1 GOT2 CDK2 | 4.29e-05 | 384 | 131 | 11 | int:CFL1 |
| Interaction | LIMS1 interactions | 4.34e-05 | 98 | 131 | 6 | int:LIMS1 | |
| Interaction | ARL8A interactions | 4.59e-05 | 99 | 131 | 6 | int:ARL8A | |
| Interaction | PPP1CA interactions | NR2C2 FMR1 ACTB ACTG1 DDB1 PTK2 NEDD8 AKAP9 KIF14 TXNDC16 ATM YWHAQ SF3A2 CDK2 KNL1 | 4.76e-05 | 696 | 131 | 15 | int:PPP1CA |
| Interaction | IGFBP3 interactions | 4.78e-05 | 61 | 131 | 5 | int:IGFBP3 | |
| Interaction | NXPH2 interactions | 6.03e-05 | 33 | 131 | 4 | int:NXPH2 | |
| Interaction | TUBA1C interactions | NR2C2 ARMC12 PPM1D PHF6 PTPN23 NEDD8 BSG KIF14 YWHAQ PATJ CNR2 CDK2 | 6.83e-05 | 478 | 131 | 12 | int:TUBA1C |
| Interaction | GRB2 interactions | KRT8 PDGFRB ANXA2P2 ACTB ACTG1 PTPN23 HCN2 CBLB ARID5A PTK2 IGF1R NISCH YWHAQ ENO1 NBR1 SF3A2 | 6.98e-05 | 806 | 131 | 16 | int:GRB2 |
| Interaction | VHL interactions | ACTB CASP8 ZHX2 TTC3 STAT3 FBXL4 NEDD8 PHPT1 BSG NISCH MRPS9 ATM CDK2 | 7.60e-05 | 561 | 131 | 13 | int:VHL |
| Interaction | FLNA interactions | NR2C2 MCPH1 ACTB ACTG1 DDB1 FBXL4 BSG KIF14 TXNDC16 YWHAQ PATJ FERMT2 NBR1 CDK2 | 8.41e-05 | 648 | 131 | 14 | int:FLNA |
| Interaction | ATG5 interactions | 8.56e-05 | 344 | 131 | 10 | int:ATG5 | |
| Interaction | IL23R interactions | 9.27e-05 | 14 | 131 | 3 | int:IL23R | |
| Interaction | DST interactions | 1.10e-04 | 287 | 131 | 9 | int:DST | |
| Interaction | IFITM1 interactions | 1.11e-04 | 355 | 131 | 10 | int:IFITM1 | |
| Interaction | INF2 interactions | 1.13e-04 | 288 | 131 | 9 | int:INF2 | |
| Interaction | COBLL1 interactions | 1.37e-04 | 76 | 131 | 5 | int:COBLL1 | |
| Interaction | PTPN11 interactions | 1.49e-04 | 368 | 131 | 10 | int:PTPN11 | |
| Interaction | TTN interactions | 1.50e-04 | 299 | 131 | 9 | int:TTN | |
| Interaction | ACTG1 interactions | MCPH1 KIF26B POTEF ACTB ACTG1 POTEE MRTFB YWHAQ PLG POTEI NBR1 CDK2 | 1.51e-04 | 520 | 131 | 12 | int:ACTG1 |
| Interaction | GAPDH interactions | NR2C2 FMR1 ACTB PTK2 RYR1 NEDD8 KIF14 YWHAQ FERMT2 ENO1 NBR1 GOT2 CDK2 KNL1 | 1.53e-04 | 686 | 131 | 14 | int:GAPDH |
| Interaction | SORBS1 interactions | 1.53e-04 | 123 | 131 | 6 | int:SORBS1 | |
| Interaction | IGF2 interactions | 1.58e-04 | 42 | 131 | 4 | int:IGF2 | |
| Interaction | NPHP4 interactions | 1.58e-04 | 236 | 131 | 8 | int:NPHP4 | |
| Interaction | ABLIM1 interactions | 1.60e-04 | 177 | 131 | 7 | int:ABLIM1 | |
| Interaction | PATJ interactions | 1.68e-04 | 125 | 131 | 6 | int:PATJ | |
| Interaction | PSMD14 interactions | NR2C2 SETX ACTB BMS1 ACTG1 DDB1 UBLCP1 PATJ ENO1 SF3A2 GOT2 KNL1 | 1.71e-04 | 527 | 131 | 12 | int:PSMD14 |
| Interaction | MAP7 interactions | 1.72e-04 | 239 | 131 | 8 | int:MAP7 | |
| Interaction | VCL interactions | 1.74e-04 | 305 | 131 | 9 | int:VCL | |
| Interaction | SLFN11 interactions | 1.77e-04 | 376 | 131 | 10 | int:SLFN11 | |
| Interaction | SQSTM1 interactions | KRT8 DNAJC13 SETX TTC28 ACTB PHF6 ACTG1 CASP8 ARHGEF18 NEDD8 BPTF IGF2R MIOS MRPS9 KIF14 FERMT2 NBR1 GOLGB1 CNR2 CDK2 | 1.77e-04 | 1257 | 131 | 20 | int:SQSTM1 |
| Interaction | ENO1 interactions | NR2C2 FMR1 MCPH1 KIF1B NEB ANKRD18B KIF14 TXNDC16 YWHAQ PLG ENO1 MED13 GOT2 CDK2 | 1.91e-04 | 701 | 131 | 14 | int:ENO1 |
| Interaction | PKNOX1 interactions | 1.96e-04 | 82 | 131 | 5 | int:PKNOX1 | |
| Interaction | XIRP1 interactions | 2.04e-04 | 18 | 131 | 3 | int:XIRP1 | |
| Interaction | AMOT interactions | 2.06e-04 | 312 | 131 | 9 | int:AMOT | |
| Interaction | PPIA interactions | NR2C2 FMR1 ANXA2P2 ACTB BMS1 PTPN23 DDB1 NEDD8 BPTF IGF2R BSG KIF14 ENO1 PRLR CDK2 KNL1 | 2.13e-04 | 888 | 131 | 16 | int:PPIA |
| Interaction | CALM1 interactions | DNAJC13 VPS13C KIF1B NEB RYR1 AKAP9 BSG SCN4A KIF14 YWHAQ ENO1 GRAMD1C NBR1 | 2.24e-04 | 626 | 131 | 13 | int:CALM1 |
| Interaction | CDX2 interactions | 2.46e-04 | 86 | 131 | 5 | int:CDX2 | |
| Interaction | NUMA1 interactions | NR2C2 TENT4B FMR1 DDB1 EML3 LIG3 NUP210 KIF14 YWHAQ ENO1 CDK2 | 2.49e-04 | 469 | 131 | 11 | int:NUMA1 |
| Interaction | TMPRSS15 interactions | 2.49e-04 | 4 | 131 | 2 | int:TMPRSS15 | |
| Interaction | RPN1 interactions | NR2C2 FRAS1 MIA3 PTPN23 PBX4 IGF1R IGF2R BSG TMEM245 NUP210 KIF14 FTO EPHA10 GOLGB1 CNR2 | 2.67e-04 | 814 | 131 | 15 | int:RPN1 |
| Interaction | TMED10 interactions | 2.74e-04 | 256 | 131 | 8 | int:TMED10 | |
| Interaction | YWHAH interactions | KRT8 SETX TTC28 KIF26B POTEF DOCK9 KIF1B EML3 WWC2 AKAP9 KIF14 PACS2 YWHAQ PATJ FERMT2 CFAP97 WWC1 CDK2 | 2.81e-04 | 1102 | 131 | 18 | int:YWHAH |
| Interaction | CLIC4 interactions | 2.87e-04 | 138 | 131 | 6 | int:CLIC4 | |
| Interaction | FBXO42 interactions | 2.96e-04 | 259 | 131 | 8 | int:FBXO42 | |
| Interaction | TUBB4B interactions | NR2C2 SETX ARMC12 POTEF ACTB EML3 FBXL4 NEDD8 BSG KIF14 YWHAQ CDK2 | 2.97e-04 | 560 | 131 | 12 | int:TUBB4B |
| Interaction | RNF123 interactions | GALNTL6 LIAS SETX MCPH1 KIF26B VPS13C BMS1 ACTG1 PBX4 RYR1 POTEE KMT2C LIG3 ATM BANK1 | 3.04e-04 | 824 | 131 | 15 | int:RNF123 |
| Interaction | LGR4 interactions | 3.20e-04 | 262 | 131 | 8 | int:LGR4 | |
| Interaction | HDAC7 interactions | 3.22e-04 | 141 | 131 | 6 | int:HDAC7 | |
| Interaction | UBE2M interactions | NR2C2 ACTB DDB1 UBLCP1 NEDD8 IGF1R IGF2R BSG NISCH PAX6 YWHAQ ENO1 CDK2 | 3.27e-04 | 651 | 131 | 13 | int:UBE2M |
| Interaction | SPIRE2 interactions | 3.28e-04 | 21 | 131 | 3 | int:SPIRE2 | |
| Interaction | SLC12A5 interactions | 3.28e-04 | 21 | 131 | 3 | int:SLC12A5 | |
| Interaction | GHR interactions | 3.36e-04 | 51 | 131 | 4 | int:GHR | |
| Interaction | ARL1 interactions | 3.38e-04 | 200 | 131 | 7 | int:ARL1 | |
| Interaction | PXN interactions | 3.41e-04 | 334 | 131 | 9 | int:PXN | |
| Interaction | CDKN2A interactions | 3.48e-04 | 335 | 131 | 9 | int:CDKN2A | |
| Interaction | HDAC6 interactions | KRT8 POTEF ACTB ACTG1 DDB1 STAT3 NEDD8 POTEE LIG3 IGF1R KIF14 ATM YWHAQ ENO1 GOLGB1 GOT2 | 3.52e-04 | 929 | 131 | 16 | int:HDAC6 |
| Interaction | FGR interactions | 3.53e-04 | 93 | 131 | 5 | int:FGR | |
| Interaction | WWC1 interactions | 3.71e-04 | 94 | 131 | 5 | int:WWC1 | |
| Interaction | SEL1L interactions | 3.74e-04 | 145 | 131 | 6 | int:SEL1L | |
| Interaction | BANF1 interactions | 3.80e-04 | 204 | 131 | 7 | int:BANF1 | |
| Interaction | CALR interactions | 3.81e-04 | 414 | 131 | 10 | int:CALR | |
| Interaction | RPP38 interactions | 3.90e-04 | 95 | 131 | 5 | int:RPP38 | |
| Interaction | AMOTL1 interactions | 3.90e-04 | 95 | 131 | 5 | int:AMOTL1 | |
| Interaction | BCL7B interactions | 3.90e-04 | 95 | 131 | 5 | int:BCL7B | |
| Interaction | H1-2 interactions | NR2C2 TENT4B BMS1 PHF6 NEB DDB1 DNTTIP2 NEDD8 IGF2R KIF14 ATM YWHAQ CDK2 | 4.06e-04 | 666 | 131 | 13 | int:H1-2 |
| Interaction | TSHR interactions | 4.09e-04 | 96 | 131 | 5 | int:TSHR | |
| Interaction | PHF21A interactions | 4.14e-04 | 343 | 131 | 9 | int:PHF21A | |
| Interaction | FGD5 interactions | 4.15e-04 | 207 | 131 | 7 | int:FGD5 | |
| Interaction | FUS interactions | NR2C2 ANXA2P2 ACTB NEDD8 BSG KIF14 ATM YWHAQ ENO1 CDH4 NBR1 SF3A2 GOT2 CDK2 | 4.16e-04 | 757 | 131 | 14 | int:FUS |
| Interaction | NADK2 interactions | 4.19e-04 | 54 | 131 | 4 | int:NADK2 | |
| Interaction | IMPDH2 interactions | 4.26e-04 | 420 | 131 | 10 | int:IMPDH2 | |
| Interaction | OCLN interactions | DNAJC13 MIA3 KIF26B IGF2R BSG NISCH KIF14 PATJ FERMT2 CFAP97 GOLGB1 | 4.29e-04 | 500 | 131 | 11 | int:OCLN |
| Cytoband | 2q21.1 | 2.53e-05 | 58 | 133 | 4 | 2q21.1 | |
| Cytoband | 3q22.1 | 2.51e-04 | 42 | 133 | 3 | 3q22.1 | |
| Cytoband | 1p36.2 | 6.36e-04 | 13 | 133 | 2 | 1p36.2 | |
| Cytoband | 19p13.3 | 6.61e-04 | 237 | 133 | 5 | 19p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q21 | 1.01e-03 | 151 | 133 | 4 | chr2q21 | |
| Cytoband | 6q26 | 1.24e-03 | 18 | 133 | 2 | 6q26 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 5.59e-07 | 13 | 98 | 4 | 685 | |
| GeneFamily | C2 and WW domain containing | 1.73e-04 | 4 | 98 | 2 | 838 | |
| GeneFamily | Actins | 4.30e-04 | 6 | 98 | 2 | 929 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 4.55e-04 | 181 | 98 | 6 | 694 | |
| GeneFamily | PHD finger proteins | 1.45e-03 | 90 | 98 | 4 | 88 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 1.98e-03 | 46 | 98 | 3 | 622 | |
| GeneFamily | Secretoglobins | 2.54e-03 | 14 | 98 | 2 | 734 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DNAJC13 SETX TTC28 DOCK9 CASP8 ZHX2 CBLB PTK2 BPTF IGF1R ATP2C1 IGF2R AKAP9 KIF14 FTO FERMT2 MED13 WWC1 | 3.50e-07 | 856 | 133 | 18 | M4500 |
| Coexpression | PILON_KLF1_TARGETS_UP | KRT8 KIF26B ACTB IRAG1 IGF1R PTAR1 MIOS ING4 PLG FERMT2 NBR1 MED13 WWC1 | 1.81e-06 | 503 | 133 | 13 | M2226 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 3.24e-06 | 300 | 133 | 10 | M8702 | |
| Coexpression | PILON_KLF1_TARGETS_UP | KRT8 KIF26B ACTB IRAG1 IGF1R PTAR1 MIOS ING4 PLG FERMT2 NBR1 MED13 WWC1 | 4.00e-06 | 541 | 133 | 13 | MM1061 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | DNAJC13 CASP8 ZHX2 CBLB PTK2 BPTF AKAP9 KIF14 FTO FERMT2 MED13 WWC1 | 4.76e-06 | 466 | 133 | 12 | M13522 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SETX FMR1 VPS13C DOCK9 ACTB CASP8 CBLB UBLCP1 EML3 ARID5A DNTTIP2 STAT3 SLC5A3 BPTF KMT2C AKAP9 NUP210 PTAR1 ATM YWHAQ ENO1 MED13 | 6.05e-06 | 1492 | 133 | 22 | M40023 |
| Coexpression | KAECH_NAIVE_VS_MEMORY_CD8_TCELL_UP | 8.66e-06 | 200 | 133 | 8 | M3020 | |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 9.54e-06 | 145 | 133 | 7 | M1810 | |
| Coexpression | TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_BETA_CELL_AGEING | 1.32e-05 | 212 | 133 | 8 | MM3816 | |
| Coexpression | GERHOLD_ADIPOGENESIS_DN | 1.87e-05 | 64 | 133 | 5 | MM671 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | SETX PHF6 PABPC4L TTC3 UBLCP1 AKAP9 WDR11 YWHAQ ZNF160 EFCAB7 CFAP97 | 1.87e-05 | 448 | 133 | 11 | MM1044 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 3.85e-05 | 180 | 133 | 7 | M8239 | |
| Coexpression | GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN | 3.85e-05 | 180 | 133 | 7 | M6878 | |
| Coexpression | GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP | 6.19e-05 | 194 | 133 | 7 | M3321 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | SETX PHF6 PABPC4L TTC3 UBLCP1 AKAP9 WDR11 YWHAQ EFCAB7 CFAP97 | 7.71e-05 | 434 | 133 | 10 | M15150 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MIA3 TTC28 COL6A6 VPS13C KIF1B TTC3 DDB1 SLC7A14 KMT2C AKAP9 NISCH SPHKAP PAX6 UNC80 GOLGB1 | 3.22e-17 | 195 | 133 | 15 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MIA3 TTC28 COL6A6 VPS13C KIF1B TTC3 SLC7A14 KMT2C AKAP9 NISCH SPHKAP PAX6 UNC80 GOLGB1 | 1.00e-15 | 195 | 133 | 14 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-10 | 194 | 133 | 10 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | GALNTL6 FRAS1 TMPRSS15 KIF26B COL22A1 NEB PCDH15 UNC80 EPHA10 | 4.63e-09 | 184 | 133 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | GALNTL6 FRAS1 TMPRSS15 KIF26B COL22A1 NEB PCDH15 UNC80 EPHA10 | 4.63e-09 | 184 | 133 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | GALNTL6 FRAS1 TMPRSS15 KIF26B COL22A1 NEB PCDH15 UNC80 EPHA10 | 4.63e-09 | 184 | 133 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-09 | 188 | 133 | 9 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.34e-09 | 194 | 133 | 9 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.84e-08 | 166 | 133 | 8 | 6a6ed5c7a43fee9a8a9be42dfa99303815b8e8ef | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.19e-08 | 180 | 133 | 8 | f6a2208960d0df1500c974cc44c3c054cd7475a9 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.25e-08 | 186 | 133 | 8 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.25e-08 | 186 | 133 | 8 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.64e-08 | 187 | 133 | 8 | 1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41 | |
| ToppCell | COVID-19-Heart-T_cell|Heart / Disease (COVID-19 only), tissue and cell type | 1.09e-07 | 190 | 133 | 8 | e6c3a6e01fef6c5b49f72661d4fb0414ba9046bf | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-07 | 192 | 133 | 8 | 1304e69c92cef3bd8c82e3c035a7562f5440139a | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-07 | 193 | 133 | 8 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-07 | 193 | 133 | 8 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-07 | 194 | 133 | 8 | 92b39a935e8c577eb1123d706d168fa13cf3344c | |
| ToppCell | wk_08-11-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.49e-07 | 198 | 133 | 8 | 84697f316d9195ebe838cf57f4dbdd9feea43bec | |
| ToppCell | wk_08-11-Epithelial-Distal_epithelial_progenitor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.49e-07 | 198 | 133 | 8 | eda85a592527992b51a00f288cff0c3239c47e6f | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.61e-07 | 200 | 133 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 5.16e-07 | 159 | 133 | 7 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.19e-07 | 167 | 133 | 7 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.43e-07 | 171 | 133 | 7 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.59e-06 | 188 | 133 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-06 | 189 | 133 | 7 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-06 | 191 | 133 | 7 | 3387b95a3f2445c672d407922fdce3a91eabaef8 | |
| ToppCell | droplet-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 192 | 133 | 7 | 0dfd1e9896c34aee0f842f8de5d0e3af62a15f68 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.89e-06 | 193 | 133 | 7 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.89e-06 | 193 | 133 | 7 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-06 | 193 | 133 | 7 | 5fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4 | |
| ToppCell | Severe-B_intermediate-10|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.24e-06 | 198 | 133 | 7 | dfae26c3513a82bb7cb8dadbfcea2a1f420b1bab | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 2.32e-06 | 199 | 133 | 7 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.32e-06 | 199 | 133 | 7 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 2.32e-06 | 199 | 133 | 7 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Macroglial-Astrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.39e-06 | 200 | 133 | 7 | 941536b7c32f1e63c70535233b2ccce0cd7bf96e | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 2.39e-06 | 200 | 133 | 7 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.39e-06 | 200 | 133 | 7 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | COVID-19-kidney-Epithelial_Doublet|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.63e-06 | 130 | 133 | 6 | 1ff28e9d3dc9a791e07d815f8fbb48f75d3f275b | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 3.88e-06 | 139 | 133 | 6 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.56e-06 | 148 | 133 | 6 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.01e-06 | 150 | 133 | 6 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | facs-Trachea-nan-3m-Myeloid-lymphocyte_of_B_lineage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.81e-06 | 157 | 133 | 6 | 0fecc14959c4c9efc19d5c06475a890e0a30f148 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 9.67e-06 | 163 | 133 | 6 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.03e-05 | 96 | 133 | 5 | 56e993d37b7958abe56682422536045550e29b41 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-05 | 98 | 133 | 5 | ffe21b3681fdeaf4a8447bd2b13772d03cdd45aa | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.27e-05 | 171 | 133 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-05 | 175 | 133 | 6 | 65571d775d26a40e979dbf290a8e4320c0d9fb3f | |
| ToppCell | Severe-B_intermediate-10|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.59e-05 | 178 | 133 | 6 | b7374a97c51239782bed658381a02cb1b3d9bf66 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 180 | 133 | 6 | 6ac62bf1251978c8c12e715f7b73144fca619794 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.75e-05 | 181 | 133 | 6 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.86e-05 | 183 | 133 | 6 | 8820cfed27b292bc0bc9cde4005219ed41900552 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-05 | 185 | 133 | 6 | c083a4974590b9ed3ecafedd3e9cdebc5047fe39 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-05 | 186 | 133 | 6 | d1d01ce46e62944aa9864eda47e8401b5f0d2bdc | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-05 | 187 | 133 | 6 | 7b2cd0c618ed081223343f3bec2244c8723c9a31 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-05 | 188 | 133 | 6 | 1efbc99bcd6542e5d9fa91edb7c4295167914786 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.17e-05 | 188 | 133 | 6 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 2.18e-05 | 112 | 133 | 5 | 9c3fb470708e76a8f8a3cb9aa17ab130c60fee11 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-05 | 189 | 133 | 6 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.30e-05 | 190 | 133 | 6 | 625c08a0e5227efc46daa512fd579c3938ff76c7 | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.30e-05 | 190 | 133 | 6 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-05 | 191 | 133 | 6 | fd01a206763dfb6d52cca67123571936b4a8e1a0 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.37e-05 | 191 | 133 | 6 | de2cd94ee88a7754f86d39469e38374d668210c7 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-05 | 191 | 133 | 6 | a251b134f67a0a1ef3a42f50042f128a17f20b22 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.44e-05 | 192 | 133 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.44e-05 | 192 | 133 | 6 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.44e-05 | 192 | 133 | 6 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.44e-05 | 192 | 133 | 6 | b7c01e12b3e9be960a741b08835f1dfff65d0d47 | |
| ToppCell | droplet-Pancreas-Endocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 192 | 133 | 6 | 4510aa262da8dcf7c944b3907a51aba5a9397a4e | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.52e-05 | 193 | 133 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 195 | 133 | 6 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 2.67e-05 | 195 | 133 | 6 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-05 | 195 | 133 | 6 | f7d9adadd37209ce1a38e5d621607b9c9270fed8 | |
| ToppCell | tumor_Lung-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 2.74e-05 | 196 | 133 | 6 | 5a0b5aeff7e535781ea2a4c85799bb468afcb6f8 | |
| ToppCell | COVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.74e-05 | 196 | 133 | 6 | ac28e9be288af6f00a841aea4ce4b99aed6b4505 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.82e-05 | 197 | 133 | 6 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 2.82e-05 | 197 | 133 | 6 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.82e-05 | 197 | 133 | 6 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.82e-05 | 197 | 133 | 6 | 5a63c2b824c7d0dbbc706e408459c9b9fe65daaa | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.90e-05 | 198 | 133 | 6 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 2.90e-05 | 198 | 133 | 6 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 2.90e-05 | 198 | 133 | 6 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.99e-05 | 199 | 133 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 2.99e-05 | 199 | 133 | 6 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.99e-05 | 199 | 133 | 6 | a900ef002e1ae583b70be0253d8c44dae6754916 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 2.99e-05 | 199 | 133 | 6 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 2.99e-05 | 199 | 133 | 6 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 2.99e-05 | 199 | 133 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.99e-05 | 199 | 133 | 6 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.99e-05 | 199 | 133 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 2.99e-05 | 199 | 133 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.07e-05 | 200 | 133 | 6 | d6fcbf4f4bc1b89a9929d7b114c6b907b6979900 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.07e-05 | 200 | 133 | 6 | f861509b54185d89931db64da1b9d81986cc7938 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.07e-05 | 200 | 133 | 6 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.07e-05 | 200 | 133 | 6 | 7a8160e6477708f22e48c609bf8f43f3715dcb03 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.07e-05 | 200 | 133 | 6 | 16f468217427921fa18c6d078ffa990eb019b257 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.07e-05 | 200 | 133 | 6 | 0442894c39eec69850c090957a5dc7bcecd21e04 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 3.07e-05 | 200 | 133 | 6 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.07e-05 | 200 | 133 | 6 | 01819446deeab9054f5cfe889d53bb49d137dbc0 | |
| ToppCell | COVID-19-kidney-Epithelial_Doublet|kidney / Disease (COVID-19 only), tissue and cell type | 3.56e-05 | 124 | 133 | 5 | d6f59ddb9b9df02b5201f23fa5fb78f3fd891ee9 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.86e-06 | 49 | 89 | 6 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.86e-06 | 49 | 89 | 6 | GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED | |
| Drug | SF6847 | 3.85e-06 | 41 | 132 | 5 | CID000005614 | |
| Drug | orthovanadate | KRT8 PDGFRB IL36B KIF1B ACTB ACTG1 PTK2 RYR1 STAT3 ATP2C1 SLC14A1 BSG | 8.99e-06 | 435 | 132 | 12 | CID000061672 |
| Drug | irofulven | 1.15e-05 | 51 | 132 | 5 | CID000148189 | |
| Drug | 2-methyl-2-nitrosopropane | 1.24e-05 | 25 | 132 | 4 | CID000023272 | |
| Drug | Puromycin dihydrochloride [58-58-2]; Down 200; 7.4uM; PC3; HT_HG-U133A | 1.27e-05 | 185 | 132 | 8 | 6711_DN | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 1.49e-05 | 189 | 132 | 8 | 3262_DN | |
| Drug | PTK/ZK | 1.83e-05 | 56 | 132 | 5 | CID000151193 | |
| Drug | CID5255110 | 2.00e-05 | 57 | 132 | 5 | CID005255110 | |
| Drug | Quin 2-AM | 2.22e-05 | 10 | 132 | 3 | CID000105103 | |
| Drug | taxol | KRT8 PDGFRB IL36B ACTB ACTG1 CASP8 SLCO1B1 PTK2 STAT3 PHPT1 ATM CNR2 CDK2 | 2.34e-05 | 560 | 132 | 13 | CID000004666 |
| Disease | Hereditary Diffuse Gastric Cancer | 6.95e-07 | 293 | 129 | 10 | C1708349 | |
| Disease | Stomach Neoplasms | 7.86e-07 | 297 | 129 | 10 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 8.61e-07 | 300 | 129 | 10 | C0024623 | |
| Disease | Uveoretinal Coloboma | 2.82e-06 | 7 | 129 | 3 | C4554007 | |
| Disease | Mammary Carcinoma, Human | KRT8 PPM1D CASP8 SLCO1B1 UBLCP1 STAT3 IGF1R NISCH ATM FTO ENO1 CNR2 | 3.53e-06 | 525 | 129 | 12 | C4704874 |
| Disease | Mammary Neoplasms, Human | KRT8 PPM1D CASP8 SLCO1B1 UBLCP1 STAT3 IGF1R NISCH ATM FTO ENO1 CNR2 | 3.53e-06 | 525 | 129 | 12 | C1257931 |
| Disease | Mammary Neoplasms | KRT8 PPM1D CASP8 SLCO1B1 UBLCP1 STAT3 IGF1R NISCH ATM FTO ENO1 CNR2 | 3.67e-06 | 527 | 129 | 12 | C1458155 |
| Disease | Moyamoya disease (implicated_via_orthology) | 4.50e-06 | 8 | 129 | 3 | DOID:13099 (implicated_via_orthology) | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 4.50e-06 | 8 | 129 | 3 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 4.50e-06 | 8 | 129 | 3 | DOID:0081112 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 4.50e-06 | 8 | 129 | 3 | DOID:14004 (implicated_via_orthology) | |
| Disease | Breast Carcinoma | KRT8 PPM1D CASP8 SLCO1B1 UBLCP1 STAT3 IGF1R NISCH ATM FTO ENO1 CNR2 | 4.52e-06 | 538 | 129 | 12 | C0678222 |
| Disease | Congenital ocular coloboma (disorder) | 6.73e-06 | 9 | 129 | 3 | C0009363 | |
| Disease | intestinal atresia (implicated_via_orthology) | 9.58e-06 | 10 | 129 | 3 | DOID:10486 (implicated_via_orthology) | |
| Disease | Congenital neurologic anomalies | 9.58e-06 | 10 | 129 | 3 | C0497552 | |
| Disease | Cranioschisis | 9.58e-06 | 10 | 129 | 3 | C0265541 | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 9.58e-06 | 10 | 129 | 3 | DOID:13832 (implicated_via_orthology) | |
| Disease | stenosing tenosynovitis | 1.74e-05 | 12 | 129 | 3 | EFO_0010822 | |
| Disease | Congenital myopathy (disorder) | 1.74e-05 | 12 | 129 | 3 | C0270960 | |
| Disease | Statin causing adverse effect in therapeutic use | 1.90e-05 | 2 | 129 | 2 | cv:C0570410 | |
| Disease | Baraitser-Winter syndrome | 1.90e-05 | 2 | 129 | 2 | cv:C1853623 | |
| Disease | Statin-induced myopathy | 1.90e-05 | 2 | 129 | 2 | cv:CN181199 | |
| Disease | Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation | 1.90e-05 | 2 | 129 | 2 | C1855722 | |
| Disease | Fryns-Aftimos Syndrome | 1.90e-05 | 2 | 129 | 2 | C1853623 | |
| Disease | Malignant neoplasm of breast | KRT8 PPM1D CASP8 TTC3 SLCO1B1 UBLCP1 STAT3 ADHFE1 IGF1R AKAP9 NISCH ATM FTO ENO1 GOLGB1 CNR2 | 1.92e-05 | 1074 | 129 | 16 | C0006142 |
| Disease | amyotrophic lateral sclerosis (biomarker_via_orthology) | 2.26e-05 | 13 | 129 | 3 | DOID:332 (biomarker_via_orthology) | |
| Disease | Intellectual Disability | 2.85e-05 | 447 | 129 | 10 | C3714756 | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 4.38e-05 | 16 | 129 | 3 | DOID:0070296 (is_implicated_in) | |
| Disease | Mammary Neoplasms, Experimental | 6.37e-05 | 155 | 129 | 6 | C0024668 | |
| Disease | Congenital hernia of foramen of Morgagni | 7.52e-05 | 19 | 129 | 3 | C0265699 | |
| Disease | Congenital hernia of foramen of Bochdalek | 7.52e-05 | 19 | 129 | 3 | C0265700 | |
| Disease | Congenital diaphragmatic hernia | 1.02e-04 | 21 | 129 | 3 | C0235833 | |
| Disease | BREAST CANCER | 1.02e-04 | 21 | 129 | 3 | 114480 | |
| Disease | Macrostomia | 1.13e-04 | 4 | 129 | 2 | C0024433 | |
| Disease | Autosomal Recessive Primary Microcephaly | 1.18e-04 | 22 | 129 | 3 | C3711387 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 1.41e-04 | 60 | 129 | 4 | C4722327 | |
| Disease | prostate carcinoma | KRT8 TTC28 CASP8 PBX4 NEDD8 IGF1R WDR11 PCDH15 ATM FERMT2 EPHA10 KNL1 MOCOS | 1.49e-04 | 891 | 129 | 13 | EFO_0001663 |
| Disease | Carcinoma, Granular Cell | 1.61e-04 | 116 | 129 | 5 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 1.61e-04 | 116 | 129 | 5 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 1.61e-04 | 116 | 129 | 5 | C0205642 | |
| Disease | Carcinoma, Cribriform | 1.61e-04 | 116 | 129 | 5 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 1.61e-04 | 116 | 129 | 5 | C0205641 | |
| Disease | Adenocarcinoma | 1.61e-04 | 116 | 129 | 5 | C0001418 | |
| Disease | Congenital coloboma of iris | 1.88e-04 | 5 | 129 | 2 | C0266551 | |
| Disease | Coloboma of choroid and retina | 1.88e-04 | 5 | 129 | 2 | C4708599 | |
| Disease | congestive heart failure (is_implicated_in) | 2.21e-04 | 27 | 129 | 3 | DOID:6000 (is_implicated_in) | |
| Disease | Malignant tumor of breast | 2.21e-04 | 27 | 129 | 3 | cv:C0006142 | |
| Disease | Breast neoplasm | 2.21e-04 | 27 | 129 | 3 | cv:C1458155 | |
| Disease | Familial cancer of breast | 2.21e-04 | 27 | 129 | 3 | cv:C0346153 | |
| Disease | Prostate cancer, familial | 2.42e-04 | 69 | 129 | 4 | C2931456 | |
| Disease | renal cell carcinoma (is_implicated_in) | 2.42e-04 | 69 | 129 | 4 | DOID:4450 (is_implicated_in) | |
| Disease | MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE | 2.81e-04 | 6 | 129 | 2 | C1854678 | |
| Disease | Breast Cancer, Familial | 3.04e-04 | 30 | 129 | 3 | C0346153 | |
| Disease | Liver carcinoma | 4.03e-04 | 507 | 129 | 9 | C2239176 | |
| Disease | urate measurement, bone density | 4.04e-04 | 619 | 129 | 10 | EFO_0003923, EFO_0004531 | |
| Disease | Animal Mammary Neoplasms | 4.10e-04 | 142 | 129 | 5 | C0024667 | |
| Disease | Mammary Carcinoma, Animal | 4.10e-04 | 142 | 129 | 5 | C1257925 | |
| Disease | endometrial carcinoma (is_marker_for) | 4.42e-04 | 34 | 129 | 3 | DOID:2871 (is_marker_for) | |
| Disease | Schizophrenia | FMR1 PDGFRB ACTB SLC12A5 NRXN3 WDR11 TMEM245 ATM CTNNA2 PAX6 PLG CNR2 | 5.10e-04 | 883 | 129 | 12 | C0036341 |
| Disease | clear cell renal cell carcinoma (is_implicated_in) | 5.22e-04 | 8 | 129 | 2 | DOID:4467 (is_implicated_in) | |
| Disease | Moderate albuminuria, diabetic nephropathy | 5.22e-04 | 8 | 129 | 2 | EFO_0000401, HP_0012594 | |
| Disease | nemaline myopathy (implicated_via_orthology) | 5.22e-04 | 8 | 129 | 2 | DOID:3191 (implicated_via_orthology) | |
| Disease | lung squamous cell carcinoma (is_marker_for) | 5.24e-04 | 36 | 129 | 3 | DOID:3907 (is_marker_for) | |
| Disease | breast cancer (is_implicated_in) | 5.27e-04 | 150 | 129 | 5 | DOID:1612 (is_implicated_in) | |
| Disease | body surface area | 5.43e-04 | 643 | 129 | 10 | EFO_0022196 | |
| Disease | aspartate aminotransferase measurement | KRT8 DNAJC13 TTC28 PBX4 WWC2 WDR11 ADAMTS6 CTNNA2 FTO BANK1 GOT2 MOCOS | 6.27e-04 | 904 | 129 | 12 | EFO_0004736 |
| Disease | Craniofacial Abnormalities | 6.29e-04 | 156 | 129 | 5 | C0376634 | |
| Disease | HEPATOCELLULAR CARCINOMA | 6.69e-04 | 9 | 129 | 2 | 114550 | |
| Disease | vitamin K measurement | 6.69e-04 | 9 | 129 | 2 | EFO_0004618 | |
| Disease | cerebrospinal fluid biomarker measurement, t-tau measurement | 6.69e-04 | 9 | 129 | 2 | EFO_0004760, EFO_0006794 | |
| Disease | Hepatocellular carcinoma | 6.69e-04 | 9 | 129 | 2 | cv:C2239176 | |
| Disease | nevus count, cutaneous melanoma | 6.94e-04 | 91 | 129 | 4 | EFO_0000389, EFO_0004632 | |
| Disease | Carcinomatosis | 7.67e-04 | 163 | 129 | 5 | C0205699 | |
| Disease | Carcinoma, Spindle-Cell | 7.67e-04 | 163 | 129 | 5 | C0205697 | |
| Disease | Undifferentiated carcinoma | 7.67e-04 | 163 | 129 | 5 | C0205698 | |
| Disease | Anaplastic carcinoma | 7.67e-04 | 163 | 129 | 5 | C0205696 | |
| Disease | Carcinoma | 7.89e-04 | 164 | 129 | 5 | C0007097 | |
| Disease | melanoma | 7.98e-04 | 248 | 129 | 6 | C0025202 | |
| Disease | JT interval | 7.98e-04 | 248 | 129 | 6 | EFO_0007885 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 8.05e-04 | 447 | 129 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | C-reactive protein measurement | IL36B VPS13C PBX4 CCDC168 EML3 STAT3 BPTF SPHKAP SCN4A PCDH15 FTO PATJ CDH4 BANK1 | 8.28e-04 | 1206 | 129 | 14 | EFO_0004458 |
| Disease | neuroblastoma (is_implicated_in) | 8.34e-04 | 10 | 129 | 2 | DOID:769 (is_implicated_in) | |
| Disease | nasopharynx carcinoma (is_marker_for) | 8.87e-04 | 43 | 129 | 3 | DOID:9261 (is_marker_for) | |
| Disease | serum metabolite measurement | KLHL1 MCPH1 KIF26B PBX4 SLCO1B1 STAT3 IGF2R PCDH15 TXNDC16 YWHAQ EPHA10 GOT2 | 9.21e-04 | 945 | 129 | 12 | EFO_0005653 |
| Disease | Gastric Adenocarcinoma | 1.01e-03 | 45 | 129 | 3 | C0278701 | |
| Disease | prostatic hypertrophy (is_marker_for) | 1.02e-03 | 11 | 129 | 2 | DOID:11132 (is_marker_for) | |
| Disease | Hand-foot syndrome, response to fluoropyrimidines | 1.02e-03 | 11 | 129 | 2 | EFO_0010825, EFO_1001893 | |
| Disease | Neoplasm Invasiveness | 1.32e-03 | 184 | 129 | 5 | C0027626 | |
| Disease | taurolithocholate 3-sulfate measurement | 1.43e-03 | 13 | 129 | 2 | EFO_0021036 | |
| Disease | pancreatic cancer (is_implicated_in) | 1.50e-03 | 112 | 129 | 4 | DOID:1793 (is_implicated_in) | |
| Disease | Squamous cell carcinoma of the head and neck | 1.54e-03 | 52 | 129 | 3 | C1168401 | |
| Disease | Drug habituation | 1.66e-03 | 115 | 129 | 4 | C0013170 | |
| Disease | Drug abuse | 1.66e-03 | 115 | 129 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 1.66e-03 | 115 | 129 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 1.66e-03 | 115 | 129 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 1.66e-03 | 115 | 129 | 4 | C0013222 | |
| Disease | Drug Dependence | 1.66e-03 | 115 | 129 | 4 | C1510472 | |
| Disease | Substance Dependence | 1.66e-03 | 115 | 129 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 1.66e-03 | 115 | 129 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.66e-03 | 115 | 129 | 4 | C0029231 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KTYGQSADGAEANEM | 441 | Q8NDB2 | |
| QGAYQEAFDISKKEM | 146 | P27348 | |
| KESNYAKLIEMNGGG | 3491 | Q99996 | |
| QQFSGENGERMKEKY | 536 | Q6ZSZ5 | |
| KQYKMAKENRGDDGA | 161 | Q03989 | |
| GDITGKKKEMENYNV | 541 | Q8IYS0 | |
| QEGASVKIMGYKDFV | 336 | Q96AK3 | |
| GMQTTENYLTEKGNE | 56 | Q9P2B7 | |
| GMHQKESYVGKEAQS | 46 | Q9BYX7 | |
| GMGQKDSYVGDEAQS | 46 | P60709 | |
| GMGQKDSYVGDEAQS | 46 | P63261 | |
| QDSQSYGKKKDEMFG | 321 | A2A2Z9 | |
| NYRKSLEGTKNNMDE | 1056 | Q12830 | |
| ADQLYDSMKGKGTRD | 271 | A6NMY6 | |
| TYFDDLKGEMQKQAQ | 846 | Q14692 | |
| MSAIEEGKGIYNNIK | 686 | P98194 | |
| GYMLDDKDNSVKTQA | 116 | Q5T9G4 | |
| AMSKNYIALKSEGDD | 751 | Q9UKP5 | |
| NGSKDGLDSNPMKDY | 11 | P34972 | |
| KMETAEYNGQITGAS | 581 | P49116 | |
| QRYKGQDGNSEAAMK | 361 | Q86VS3 | |
| TMDVIGGKYNSAKKD | 301 | Q9H3S7 | |
| GNMQGLVEDFKNKYE | 166 | P05787 | |
| ASEKQQMGADGMYDK | 131 | P26367 | |
| GGSYVAKDEVQKNML | 336 | Q8NDF8 | |
| SYISEMEKAAKQGDT | 191 | Q8TEM1 | |
| GMHQKESYVGKEAQS | 746 | A5A3E0 | |
| KLAAMKELYESNGSN | 1146 | Q15058 | |
| YDNEGDQVKNGTNMK | 3866 | Q86XX4 | |
| KDIDDNSNGTYEKMQ | 171 | Q8NEZ4 | |
| KQAAGMSQETFEEKY | 316 | Q8NEM0 | |
| SGKQMNDEKTAADYK | 46 | Q15843 | |
| KMSDAQGSYKLDEAQ | 201 | Q8IX03 | |
| MGSSYNGQDEVDIKS | 181 | Q9C0B1 | |
| AGKSYTMMGKQEESQ | 101 | O60333 | |
| GKSYTMIGKDDSMQN | 551 | Q2KJY2 | |
| NMEKTVFQKEGNYGD | 446 | P98073 | |
| NVDAKIAKLMGEGYA | 931 | Q13191 | |
| AGEIADGMAYLNANK | 1116 | P08069 | |
| MEEEAYSKGFQEGLK | 771 | Q9Y6F6 | |
| MQKSKEQGYGKLSSD | 6 | Q8IYB4 | |
| DQKGEKNEPQMDSNY | 301 | Q9ULH7 | |
| NGAKNLDLKGDLYMA | 981 | Q9Y4C0 | |
| GSKGEYQIKMENFDK | 306 | O60928 | |
| ESKGNDITIYGNDFM | 331 | Q8NG31 | |
| GLGENDEQVYATMKA | 281 | O43766 | |
| LNSLDEQEGVKSGMY | 91 | O75223 | |
| DDKGNIIGYSQVDKM | 396 | Q96EN8 | |
| DQEEKKYLMGEHGQS | 331 | O15297 | |
| EKGQSEQTYSMVKTG | 496 | Q5JZY3 | |
| MQAGPKAKSTDNYSE | 186 | Q86VP3 | |
| VKKDYLNEGAMADTA | 676 | P49916 | |
| GMHQKESYVGKEAQS | 746 | Q6S8J3 | |
| NMGKFQEEATIYTGK | 271 | Q9BYU1 | |
| VKATDKDTGNYSVMA | 1166 | Q96QU1 | |
| DNDKTRYMGKGVSKA | 51 | P06733 | |
| EMDGTENKSKFGANA | 96 | P06733 | |
| YDGESSDELRNGKMK | 2371 | Q13315 | |
| DKEKSYVTDDGQGMG | 456 | Q06787 | |
| TEFSDKEKGNMVYLG | 51 | Q9NZH7 | |
| NMNDAGIYSLSVGDK | 301 | Q8N9C0 | |
| YSDKFGSENVKMIQD | 1836 | Q9BZ29 | |
| LSEYMNNTGRKEKGD | 346 | P26232 | |
| VLSNGDAKVMDGYEN | 536 | A8K855 | |
| YAEKDGCGMDSLNKK | 251 | Q9UKA2 | |
| YKITDSEDKALMNGS | 256 | P35613 | |
| KGTQYETNSMDFKVG | 66 | P55283 | |
| MELVFAEEKYNKSGQ | 621 | O15033 | |
| ENKAVEYNAVGAMKD | 331 | Q8NFW1 | |
| VNYEVSNKDDKKNMG | 446 | Q14790 | |
| ENMIKKGDCDKTYGS | 1661 | O75165 | |
| KDGNFIMSNSGDYEI | 736 | Q32P44 | |
| EGDSASEVQKAKDYM | 4321 | Q8NDH2 | |
| MENFQKVEKIGEGTY | 1 | P24941 | |
| KGKTMADSSYNLEVQ | 476 | Q96AC1 | |
| KGVESEFYLAMNKEG | 111 | P21781 | |
| GGNAEVQQKMLDYLK | 3806 | P21817 | |
| NKEMKLSDGSYFGEI | 596 | Q9UL51 | |
| NLQYDDGSGMKREAT | 1111 | Q16531 | |
| MSINGSEENFDYLKG | 236 | A6NMZ7 | |
| KEFGDDKVQLAMQTY | 76 | Q9UNL4 | |
| DMKGDVKYADIESSN | 756 | P09619 | |
| SSKVMSDDQGSKGYA | 126 | P0CB38 | |
| DTEKGKEYDGKNMAL | 56 | Q9H2X9 | |
| YGAAVTKEVGMDLKN | 56 | Q8IWW8 | |
| MNDKGELYGSEKLTS | 121 | Q9NP95 | |
| DYESIQKEAMRSGKG | 71 | Q49A17 | |
| MKEKGNIQLSYSDGD | 556 | P11717 | |
| NLVDGMYSKQDKGGV | 786 | Q2M3C7 | |
| MSNFAYVKKESGIDD | 1501 | P35499 | |
| MEVDGLNDSSKQGYS | 336 | Q7Z6K3 | |
| LQGDYKDVVNMKESS | 121 | Q6UWJ1 | |
| ENTEKYMGTESQGSA | 881 | Q5JRA6 | |
| QGEYEEALKMAVKQG | 61 | Q14596 | |
| TIQYSNSEDKDRKGM | 301 | Q05397 | |
| GKYNVNEDAKAAMTE | 51 | P0DMR2 | |
| PASYNKEESEQMGKT | 616 | Q7Z333 | |
| YSNGQAALMGEKERK | 631 | P53794 | |
| GMHQKESYVGKEAQS | 746 | P0CG38 | |
| KEGDGSNMDQEYGTA | 961 | Q9UHV7 | |
| IYDKVSGDMQKQGCD | 56 | Q9NRX4 | |
| ENYDGKISKTMSGLE | 191 | P00747 | |
| GYKVTKQRDSEMGQQ | 116 | Q15428 | |
| ENKSVAGLTMTYDGN | 431 | Q9Y6L6 | |
| NSKKMNLGVGAYRDD | 56 | P00505 | |
| DNEMLIGKSDKSTYN | 491 | Q8TBB6 | |
| KYSEIMAEKAANAAG | 731 | Q5QJE6 | |
| GVQDKAKYIENMSRG | 306 | Q8IWS0 | |
| TMKTAKEDFSEAGNY | 536 | Q9P2K2 | |
| RDDTGNYKGVLMAQK | 146 | Q9HCG1 | |
| MTSQYQEGDDSMGKK | 371 | Q8N7U7 | |
| QIDKKMSGGQSGYEL | 201 | Q6AWC2 | |
| DANLEGKKDSGMLKY | 1546 | Q8N2C7 | |
| SDDGTVGKYGNEMKL | 251 | Q9BX84 | |
| YTEDMDQKSPGNKGS | 436 | Q9NXC5 | |
| QYDEQGMAFSKSEGK | 261 | P82933 | |
| KGDTSQNEKLSMFYE | 26 | Q8NI35 | |
| YKTLKSQGDMQDLNG | 176 | P40763 | |
| FGNKTTGKMENYELI | 1296 | Q9Y2I1 | |
| ENNKEYAKVSGVMDN | 541 | P16471 | |
| SNASEMYTQKNDGKE | 1581 | P53804 | |
| SMIDISYKQDKNGSQ | 2026 | Q709C8 | |
| GKGLAAITMDKEYQQ | 3486 | Q709C8 | |
| GKYNVNEDAKAAMTE | 51 | Q8TD33 | |
| GYVTGDMKELANQLK | 36 | Q13336 | |
| MGESQSKKLQGGYEC | 66 | Q9Y6X8 | |
| MSVGTLYEKQNGKES | 251 | Q9H330 | |
| EKSTGYMQQDLDVAK | 251 | Q96AY4 | |
| EAKMKELGVSTNANY | 191 | Q8WVY7 | |
| SLQDMYGQEKSKEQT | 56 | Q68EA5 | |
| QEGYFGQVKITSEKM | 136 | Q9HCL3 | |
| KGNQKLIAMYNDGAE | 761 | Q9BZH6 | |
| SLNKYIEEMKAQGGT | 106 | Q14789 | |
| GMDNNKGATTIEKYD | 466 | Q9NR64 | |
| ENFSSVLYKENMGKG | 6271 | P20929 |